Skip to main content
. 2024 Jul 9;12:1399689. doi: 10.3389/fbioe.2024.1399689

FIGURE 6.

FIGURE 6

Application of the capture method based on Fe3O4@ZrO2 in Clinical Samples. (A) The relative expression levels of hsa-miR-148a in EVs associated with prostate cancer based on Fe3O4@ZrO2 in persons with prostate cancer and healthy controls. (B) The relative expression levels of hsa-miR-26b in EVs associated with prostate cancer based on Fe3O4@ZrO2 in persons with prostate cancer and healthy controls. (C) The relative expression levels of hsa-miR-29a in EVs associated with prostate cancer based on Fe3O4@ZrO2 in persons with prostate cancer and healthy controls. (D) ROC curve of a model established by EV miRNAs associated with prostate cancer. ****p < 0. 0001. All data are represented as mean ± SEM.